Total Payments
$134,538
2024 Payments
$23,188
Companies
31
Transactions
286
Medicare Patients
439
Medicare Billing
$15,511
Payment Breakdown by Category
Consulting$84,849 (63.1%)
Other$26,510 (19.7%)
Research$10,950 (8.1%)
Travel$7,425 (5.5%)
Food & Beverage$4,690 (3.5%)
Education$114.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $84,849 | 49 | 63.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,520 | 6 | 19.0% |
| Unspecified | $10,950 | 6 | 8.1% |
| Travel and Lodging | $7,425 | 36 | 5.5% |
| Food and Beverage | $4,690 | 180 | 3.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $990.00 | 1 | 0.7% |
| Education | $114.33 | 8 | 0.1% |
Payments by Type
General
$123,588
280 transactions
Research
$10,950
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sebela Women's Health Inc. | $71,825 | 29 | $0 (2024) |
| Lumenis Ltd. | $17,598 | 4 | $0 (2021) |
| Lupin Inc. | $15,725 | 35 | $0 (2020) |
| Exeltis, USA Inc. | $9,731 | 39 | $0 (2022) |
| Mission Pharmacal Company | $9,265 | 14 | $0 (2018) |
| OraSure Technologies Inc. | $3,000 | 1 | $0 (2018) |
| Olympus Corporation of the Americas | $2,695 | 29 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $1,155 | 5 | $0 (2017) |
| Medicines360 | $690.73 | 5 | $0 (2018) |
| AMAG Pharmaceuticals, Inc. | $548.11 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,188 | 11 | Sebela Women's Health Inc. ($23,188) |
| 2023 | $28,950 | 11 | Sebela Women's Health Inc. ($28,950) |
| 2022 | $20,242 | 26 | Sebela Women's Health Inc. ($19,688) |
| 2021 | $4,572 | 51 | Lumenis Ltd. ($3,050) |
| 2020 | $388.24 | 19 | Exeltis, USA Inc. ($191.73) |
| 2019 | $14,289 | 59 | Lupin Inc. ($11,072) |
| 2018 | $23,263 | 68 | Lumenis, Inc ($11,210) |
| 2017 | $19,646 | 41 | Mission Pharmacal Company ($9,217) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,012.50 | General |
| 11/01/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,487.50 | General |
| 09/27/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| 08/30/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,837.50 | General |
| 07/25/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 06/27/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| 05/30/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| 04/25/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 03/28/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,662.50 | General |
| 03/01/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,975.00 | General |
| 01/18/2024 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 12/22/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,712.50 | General |
| 12/01/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,537.50 | General |
| 10/27/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 10/02/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 08/31/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $3,062.50 | General |
| 07/28/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| 06/29/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 05/30/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| 04/21/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $3,062.50 | General |
| 03/31/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 01/12/2023 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,837.50 | General |
| 12/30/2022 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $2,887.50 | General |
| 11/18/2022 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 09/30/2022 | Sebela Women's Health Inc. | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| MPC-SHRC-002 | Mission Pharmacal Company | $7,950 | 5 |
| Point of Care performance OraQuick Zika Rapid Antibody Test | OraSure Technologies Inc. | $3,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 133 | 144 | $19,435 | $3,381 |
| 2021 | 5 | 197 | 245 | $31,489 | $7,154 |
| 2020 | 3 | 109 | 122 | $16,187 | $4,977 |
Total Patients
439
Total Services
511
Medicare Billing
$15,511
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 35 | $9,625 | $1,285 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $6,000 | $689.28 | 11.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 14 | 14 | $630.00 | $608.44 | 96.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 12 | 12 | $660.00 | $579.78 | 87.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 59 | 63 | $2,520 | $218.19 | 8.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 33 | $9,900 | $2,289 | 23.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 54 | $14,850 | $2,267 | 15.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 31 | 31 | $1,393 | $1,344 | 96.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 18 | 18 | $986.13 | $874.26 | 88.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 85 | 109 | $4,360 | $379.32 | 8.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 45 | 45 | $1,952 | $1,941 | 99.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 33 | 46 | $12,650 | $1,563 | 12.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 31 | 31 | $1,585 | $1,472 | 92.9% |
About Dr. Scott Eder, MD
Dr. Scott Eder, MD is a Gynecology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083614150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Eder, MD has received a total of $134,538 in payments from pharmaceutical and medical device companies, with $23,188 received in 2024. These payments were reported across 286 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($84,849).
As a Medicare-enrolled provider, Eder has provided services to 439 Medicare beneficiaries, totaling 511 services with total Medicare billing of $15,511. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Princeton, NJ
- Active Since 07/29/2005
- Last Updated 06/11/2022
- Taxonomy Code 207VG0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083614150
Products in Payments
- SOLOSEC (Drug) $15,725
- Vitafol Ultra (Drug) $5,007
- Lumenis Pulse 120H (Device) $3,050
- OraQuick Zika Rapid Antibody Test (Device) $3,000
- ThunderBeat (Device) $2,695
- SELECT-OB PLUS DHA (Drug) $2,289
- SLYND (Drug) $1,527
- ADDYI (Drug) $1,155
- Strovite One (Drug) $900.00
- Liletta (Device) $690.73
- INTRAROSA (Drug) $503.00
- Prolia (Biological) $185.92
- BIJUVA (Drug) $182.76
- Phexxi (Drug) $147.60
- LO LOESTRIN FE (Drug) $132.10
- NovaSure (Device) $131.25
- EVENITY (Biological) $101.98
- ORIAHNN (Drug) $95.37
- LILETTA (Drug) $94.12
- ANNOVERA (Drug) $93.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.